← Back to Search

PET Imaging for Prostate Cancer

N/A
Waitlist Available
Led By Di (Maria) Jiang
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will use special imaging techniques to study advanced prostate cancer in patients. The goal is to understand how the tumors change at different stages of the disease and during treatment. This information could be helpful in

Who is the study for?
This trial is for individuals with advanced prostate cancer. It aims to understand tumor biology using specialized imaging techniques, which could guide treatment choices and monitor responses in the future.
What is being tested?
The study tests the use of two types of PET scans: Ga 68 PSMA-11 and FDG PET, along with a third type called 18F-DCFPyL PET. These scans are used to visualize cancer activity and may inform better treatment strategies.
What are the potential side effects?
PET scans are generally safe but can include discomfort from injection, allergic reactions to tracers, or exposure to low levels of radiation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: PSMA and FDG PET ImagingExperimental Treatment3 Interventions
Participants advanced prostate cancer will undergo PSMA and FDG PET prior to starting their standard of care treatment and during treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FDG PET
2017
N/A
~30

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,520 Previous Clinical Trials
503,214 Total Patients Enrolled
66 Trials studying Prostate Cancer
15,592 Patients Enrolled for Prostate Cancer
Di (Maria) JiangPrincipal InvestigatorPrincess Margaret Cancer Centre/University Health Network
~20 spots leftby Mar 2029
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top